Personalized treatment of well-differentiated gastric neuroendocrine tumors based on clinicopathological classification and grading: A multicenter retrospective study
CONCLUSIONS: Individualized treatment strategies may reduce the risk of relapse after G-NET treatment. Long-term SSA therapy may be a secure and efficacious treatment option for type 1 G-NET with more than six lesions, and it substantially decreases the incidence of post-treatment recurrence.PMID:38384175 | DOI:10.1097/CM9.0000000000003029
Source: Chinese Medical Journal - Category: General Medicine Authors: Ju Huang Huimin Liu Dekun Yang Tianming Xu Jing Wang Jingnan Li Source Type: research
More News: Brain | China Health | Gastroenterology | General Medicine | Lower Endoscopy | Neurology | Neurosurgery | Study